Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update

被引:17
作者
Choueiri, T. K. [1 ]
Eto, M. [2 ]
Kopyltsov, E. [3 ]
Rha, S. Y. [4 ]
Porta, C. G. [5 ]
Motzer, R. [6 ]
Gruenwald, V. [7 ,8 ]
Hutson, T. E. [9 ]
Mendez-Vidal, M. J. [10 ]
Hong, S-H. [11 ]
Winquist, E. [12 ]
Goh, J. C. H. [13 ,14 ]
Maroto, P. [15 ]
Buchler, T. [16 ,17 ]
Takagi, T. [18 ]
Rodriguez-Lopez, K. [19 ]
Xing, D. [20 ]
Smith, A. D. [21 ]
Powles, T. [22 ,23 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Kyushu Univ, Dept Urol, Fukuoka, Japan
[3] State Inst Healthcare Reg Clin Oncol Dispe, Oncol, Omsk, Russia
[4] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea
[5] Univ Bari A Moro, Dept Biomed Sci & Human Oncol, Bari, Italy
[6] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[7] Univ Hosp Essen, Clin Med Oncol, Essen, Germany
[8] Univ Hosp Essen, Urol Clin, Essen, Germany
[9] Texas Oncol, Med Oncol, Dallas, TX 8 USA
[10] Hosp Univ Reina Sofia, Maimonides Inst Biomed Res Cordoba IMIBIC, Dept Oncol, Cordoba, Spain
[11] Catholic Univ Korea, Seoul St Marys Hosp, Dept Urol, Seoul, South Korea
[12] Univ Western Ontario, Dept Oncol, London, ON, Canada
[13] ICON Res, South Brisbane, Qld, Australia
[14] Univ Queensland, St Lucia, Qld, Australia
[15] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain
[16] Charles Univ Prague, Dept Oncol, Prague, Czech Republic
[17] Thomayer Univ Hosp, Prague, Czech Republic
[18] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[19] Merck & Co Inc, Clin Res, Kenilworth, NJ USA
[20] Eisai Inc, Oncol Business Grp, Biostat, Woodcliff Lake, NJ USA
[21] Eisai Ltd, Clin Res, Hatfield, Herts, England
[22] Queen Mary Univ London, Barts Canc Inst, London, England
[23] Queen Mary Univ London, Royal Free Hosp, London, England
关键词
D O I
10.1016/j.annonc.2021.08.056
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
660P
引用
收藏
页码:S683 / S685
页数:4
相关论文
empty
未找到相关数据